Whole body 18F-2-deoxyglucose positron emission tomography to restage non-small cell lung cancer

Oncology Reports

Volumn 8, Issue 2, 2001, Pages 337-339

  Sheng Pinchangla, I ^a  

^a TAICHUNG VETERANS GENERAL HOSPITAL   (Taiwan)

Author keywords

18F 2 deoxyglucose positron emission tomography; Non small cell lung cancer

Indexed keywords

DIAGNOSTIC AGENT; FLUORODEOXYGLUCOSE F 18; RADIOPHARMACEUTICAL AGENT;

ARTICLE; BIOPSY; CANCER STAGING; COMPUTER ASSISTED EMISSION TOMOGRAPHY; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; HUMAN; LUNG NON SMALL CELL CANCER; LUNG TUMOR; LYMPH NODE METASTASIS; MALE; METHODOLOGY; PATHOLOGY; RADIOGRAPHY; REPRODUCIBILITY; RETROSPECTIVE STUDY; SCINTISCANNING;

BIOPSY; CARCINOMA, NON-SMALL-CELL LUNG; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; LUNG NEOPLASMS; LYMPHATIC METASTASIS; MALE; NEOPLASM STAGING; RADIOPHARMACEUTICALS; REPRODUCIBILITY OF RESULTS; RETROSPECTIVE STUDIES; TOMOGRAPHY, EMISSION-COMPUTED; TOMOGRAPHY, X-RAY COMPUTED;

EID: 0035286186     PISSN: 1021335X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (2)

1. Armstrong P and Vincent JM: Staging non-small cell lung cancer. Clin Radiol 48: 1-10, 1993.
2. White PG, Adams H, Crane MD and Butchart EG: Preoperativc staging of carcinoma of the bronchus: can computed tomographic scanning reliably identify stage III tumors? Thorax 49: 951-957, 1994.